UroGen Pharma Ltd (URGN) Insider Trading
- $541,408.92
- $10,122,830.19
- Jan. 31, 2025
- Mark Schoenberg
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 20, 2019 | CFO | 1,416 | $33.07 | Sell | $46,827.12 | |
| Aug. 15, 2019 | COO | 608 | $31.65 | Sell | $19,243.20 | |
| May 14, 2019 | COO | 608 | $37.98 | Sell | $23,091.84 | |
| March 21, 2019 | Insider | 272 | $37.01 | Buy | $10,066.72 | |
| March 6, 2019 | Insider | 1,991 | $37.30 | Sell | $74,264.30 | |
| Nov. 28, 2017 | Major Shareholder | 209,298 | $40.60 | Sell | $8,497,498.80 |
Insiders are both buying and selling UroGen Pharma Ltd stock.
The insider traders at UroGen Pharma Ltd are: Mark Schoenberg, Jason Drew Smith, Stephen Mullennix, Peter P Pfreundschuh, Elizabeth A Barrett, Molly Henderson, and Proquest Investments Iv, L.P.
The most active insider trader at UroGen Pharma Ltd is Mark Schoenberg with 28 trades.
Proquest Investments Iv, L.P. has sold the most UroGen Pharma Ltd stock with a total value of $16,994,997.60.
Elizabeth A Barrett has bought the most UroGen Pharma Ltd stock with a total value of $619,408.00.
The most recent insider trade for UroGen Pharma Ltd was on Jan. 31, 2025.
The single biggest insider buy for UroGen Pharma Ltd was from Elizabeth A Barrett with a total value of $209,160.00 on Nov. 20, 2019.
The single biggest insider sell for UroGen Pharma Ltd was from Proquest Investments Iv, L.P. with a total value of $8,497,498.80 on Nov. 28, 2017.